Advanced search
Publication Cover
Clinical Ophthalmology Volume 17, 2023 - Issue
Submit an article Journal homepage
198
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

A Randomized, Prospective, Observer-Masked Study Comparing Dropless Treatment Regimen Using Intracanalicular Dexamethasone Insert, Intracameral Ketorolac, and Intracameral Moxifloxacin versus Conventional Topical Therapy to Control Postoperative Pain and Inflammation in Cataract Surgery

Eric D Donnenfeld1 Ophthalmic Consultants of Long Island, New York, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5235-1780View further author information
ORCID Icon,
John A Hovanesian2 Harvard Eye Associates, Laguna Hills, CA, USAORCID Iconhttps://orcid.org/0000-0001-8060-8750View further author information
ORCID Icon,
Aysha G Malik1 Ophthalmic Consultants of Long Island, New York, NY, USAView further author information
&
Aidan Wong1 Ophthalmic Consultants of Long Island, New York, NY, USAView further author information
Pages 2349-2356 | Received 22 May 2023, Accepted 08 Aug 2023, Published online: 15 Aug 2023

References

  • Assil KK, Greenwood MD, Gibson A, Vantipalli S, Metzinger JL, Goldstein MH. Dropless cataract surgery: modernizing perioperative medical therapy to improve outcomes and patient satisfaction. Curr Opin Ophthalmol. 2021;32(Suppl 1):S1–S12. doi:10.1097/ICU.0000000000000708
  • Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010;12(3):348–360. doi:10.1208/s12248-010-9183-3
  • Urtti A, Salminen L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 1993;37(6):435–456. doi:10.1016/0039-6257(93)90141-S
  • Agrahari V, Mandal A, Agrahari V, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;6(6):735–754. doi:10.1007/s13346-016-0339-2
  • Matossian C. Noncompliance with prescribed eyedrop regimens among patients undergoing cataract surgery—prevalence, consequences, and solutions. US Ophthalmic Rev. 2020;13(1):18–22. doi:10.17925/USOR.2020.13.1.18
  • Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45(2):204–212. doi:10.1016/j.jcrs.2018.09.023
  • Vandenbroeck S, De Geest S, Dobbels F, Fieuws S, Stalmans I, Zeyen T. Prevalence and correlates of self-reported nonadherence with eye drop treatment: the Belgian Compliance Study in Ophthalmology (BCSO). J Glaucoma. 2011;20(7):414–421. doi:10.1097/IJG.0b013e3181f7b10e
  • Hermann MM, Ustundag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30(4):385–390. doi:10.1007/s10792-010-9362-3
  • An JA, Kasner O, Samek DA, Levesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40(11):1857–1861. doi:10.1016/j.jcrs.2014.02.037
  • Lindstrom L, Stewart Galloway R, Grzybowski M, Liegner T. Dropless cataract surgery: an overview. Curr Pharm Des. 2017;23(4):558–564. doi:10.2174/1381612822666161129150628
  • Donnenfeld ED, Solomon KD, Matossian C. Safety of IBI-10090 for inflammation associated with cataract surgery: phase 3 multicenter study. J Cataract Refract Surg. 2018;44(10):1236–1246. doi:10.1016/j.jcrs.2018.07.015
  • Walters T, Endl M, Elmer TR, Levenson J, Majmudar P, Masket S. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2015;41(10):2049–2059. doi:10.1016/j.jcrs.2015.11.005
  • Larsen J, Whitt T, Parker B, Swan R. A randomized, controlled, prospective study of the effectiveness and safety of an intracanalicular dexamethasone ophthalmic insert (0.4 Mg) for the treatment of post-operative inflammation in patients undergoing Refractive Lens Exchange (RLE). Clin Ophthalmol. 2021;15:2211–2217. doi:10.2147/OPTH.S311070
  • Hovanesian JA, Donnenfeld ED. Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery. J Cataract Refract Surg. 2022;48(8):906–911. doi:10.1097/j.jcrs.0000000000000887
  • Endophthalmitis Study Group ESoC, Refractive S. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–988. doi:10.1016/j.jcrs.2007.02.032
  • Shorstein NH, Winthrop KL, Herrinton LJ. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2013;39(1):8–14. doi:10.1016/j.jcrs.2012.07.031
  • Barber BL, Strahlman ER, Laibovitz R, Guess HA, Reines SA. Validation of a questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology. 1997;104(2):334–342. doi:10.1016/S0161-6420(97)30314-5
  • Ishrat S, Nema N, Chandravanshi SCL. Incidence and pattern of dry eye after cataract surgery. Saudi J Ophthalmol. 2019;33(1):34–40. doi:10.1016/j.sjopt.2018.10.009

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.